These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 25829202

  • 1. Synthesis and antibacterial evaluation of some teicoplanin pseudoaglycon derivatives containing alkyl- and arylthiosubstituted maleimides.
    Csávás M, Miskovics A, Szűcs Z, Rőth E, Nagy ZL, Bereczki I, Herczeg M, Batta G, Nemes-Nikodém É, Ostorházi E, Rozgonyi F, Borbás A, Herczegh P.
    J Antibiot (Tokyo); 2015 Sep; 68(9):579-85. PubMed ID: 25829202
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Lipophilic teicoplanin pseudoaglycon derivatives are active against vancomycin- and teicoplanin-resistant enterococci.
    Szűcs Z, Bereczki I, Csávás M, Rőth E, Borbás A, Batta G, Ostorházi E, Szatmári R, Herczegh P.
    J Antibiot (Tokyo); 2017 May; 70(5):664-670. PubMed ID: 28144040
    [Abstract] [Full Text] [Related]

  • 4. Synthesis of isoindole and benzoisoindole derivatives of teicoplanin pseudoaglycon with remarkable antibacterial and antiviral activities.
    Sipos A, Török Z, Rőth E, Kiss-Szikszai A, Batta G, Bereczki I, Fejes Z, Borbás A, Ostorházi E, Rozgonyi F, Naesens L, Herczegh P.
    Bioorg Med Chem Lett; 2012 Dec 01; 22(23):7092-6. PubMed ID: 23099097
    [Abstract] [Full Text] [Related]

  • 5. New semisynthetic teicoplanin derivatives have comparable in vitro activity to that of oritavancin against clinical isolates of VRE.
    Szűcs Z, Ostorházi E, Kicsák M, Nagy L, Borbás A, Herczegh P.
    J Antibiot (Tokyo); 2019 Jul 01; 72(7):524-534. PubMed ID: 30874609
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and study of antibacterial activities of antibacterial glycopeptide antibiotics conjugated with benzoxaboroles.
    Printsevskaya SS, Reznikova MI, Korolev AM, Lapa GB, Olsufyeva EN, Preobrazhenskaya MN, Plattner JJ, Zhang YK.
    Future Med Chem; 2013 Apr 01; 5(6):641-52. PubMed ID: 23617428
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics.
    Printsevskaya SS, Pavlov AY, Olsufyeva EN, Mirchink EP, Preobrazhenskaya MN.
    J Med Chem; 2003 Mar 27; 46(7):1204-9. PubMed ID: 12646030
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antibacterial activity of a novel series of 3-bromo-4-(1H-3-indolyl)-2,5-dihydro-1H-2,5-pyrroledione derivatives--an extended structure-activity relationship study.
    Mahboobi S, Eichhorn E, Winkler M, Sellmer A, Möllmann U.
    Eur J Med Chem; 2008 Mar 27; 43(3):633-56. PubMed ID: 17624634
    [Abstract] [Full Text] [Related]

  • 13. Diazo transfer-click reaction route to new, lipophilic teicoplanin and ristocetin aglycon derivatives with high antibacterial and anti-influenza virus activity: an aggregation and receptor binding study.
    Pintér G, Batta G, Kéki S, Mándi A, Komáromi I, Takács-Novák K, Sztaricskai F, Röth E, Ostorházi E, Rozgonyi F, Naesens L, Herczegh P.
    J Med Chem; 2009 Oct 08; 52(19):6053-61. PubMed ID: 19791806
    [Abstract] [Full Text] [Related]

  • 14. Microwave-assisted synthesis of diverse pyrrolo[3,4-c]quinoline-1,3-diones and their antibacterial activities.
    Xia L, Idhayadhulla A, Lee YR, Kim SH, Wee YJ.
    ACS Comb Sci; 2014 Jul 14; 16(7):333-41. PubMed ID: 24749663
    [Abstract] [Full Text] [Related]

  • 15. Synthesis, and cytotoxic activity of N(ind)-alkoxy derivatives of antibiotic arcyriarubin and dechloro-rebeccamycin aglycon.
    Lakatosh SA, Balzarini J, Andrei G, Snoeck R, Lakatosh A, De Clercq E, Preobrazhenskaya MN.
    J Antibiot (Tokyo); 2002 Aug 14; 55(8):768-73. PubMed ID: 12374389
    [No Abstract] [Full Text] [Related]

  • 16. Biosynthesis, biotechnological production, and application of teicoplanin: current state and perspectives.
    Jung HM, Jeya M, Kim SY, Moon HJ, Kumar Singh R, Zhang YW, Lee JK.
    Appl Microbiol Biotechnol; 2009 Sep 14; 84(3):417-28. PubMed ID: 19609520
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Octapeptide derivatives of teicoplanin antibiotics.
    Malbarba A, Ciabatti R, Scotti R, Goldstein BP.
    J Antibiot (Tokyo); 1993 Apr 14; 46(4):661-7. PubMed ID: 8501008
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Non-natural aglycones of glycopeptide antibiotics of the vancomycin group. Synthesis and antibacterial activity].
    Pavlov AIu, Olsuf'eva EN, Miroshnikova OV, Reznikova MI, Lazhko EI, Malabarba A, Ciabatti R, Preobrazhenskaia MN.
    Bioorg Khim; 1997 May 14; 23(5):410-21. PubMed ID: 9290051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.